CompletedPhase 4NCT02784743

Impact of Albendazole -Ivermectin on Wuchereria Bancrofti in Mali

Studying Filariasis

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Centre d'Appui à la lutte contre la Maladie
Principal Investigator: Sékou F Traoré, PhD
Malaria Research and Training Center, Mali
Intervention: ''albendazole'' and ''ivermectin''(drug)
Enrollment: 1139 enrolled
Eligibility: 5-65 years · All sexes
Timeline: 2001 – 2015

Collaborators

Malaria Research and Training Center, Bamako, Mali · World Health Organization

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02784743 on ClinicalTrials.gov

Other trials for Filariasis

Additional recruiting or active studies for the same condition.

RECRUITINGNCT00001230
Host Response to Infection and Treatment in Filarial Diseases
National Institute of Allergy and Infectious Diseases (NIAID)

See all trials for Filariasis →

← Back to all trials